Clinical leaders often face the challenge of balancing trial design and patient burden while at the same time trying to make trials efficient. As a result, ZS recently collaborated with Tufts CSDD on a global study to dig more into this space. Listen on-demand to the conversation with clinical experts from Tufts and ZS to:
Assess patient burden as a measure in drug development
Gain insights from a global patient burden study bringing enhanced understanding of this measure
